Search

Your search keyword '"de Luca, G."' showing total 3,577 results

Search Constraints

Start Over You searched for: Author "de Luca, G." Remove constraint Author: "de Luca, G."
3,577 results on '"de Luca, G."'

Search Results

102. The Ginger project – preliminary results

103. Hyperbolic compactification of M-theory and de Sitter quantum gravity

104. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature

105. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

106. Primary progressive aphasia and motor neuron disease: A review

107. Evolving Trends in the Management of Acute Appendicitis During COVID-19 Waves: The ACIE Appy II Study

108. Correction: Evolving Trends in the Management of Acute Appendicitis During COVID-19 Waves: The ACIE Appy II Study (World Journal of Surgery, (2022), 46, 9, (2021-2035), 10.1007/s00268-022-06649-z)

109. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology

110. A multi-component, adaptive Working Memory Assessment Battery (WoMAB): validation and norms in an Italian population sample

111. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

117. La Differenziazione didattica come via per promuovere l’inclusione e il rinnovamento a scuola

118. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

119. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology

120. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

121. Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

122. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

124. POS0948 PATTERNS OF DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS PATIENTS WITH INTERSTITIAL LUNG DISEASE

125. POS0541 INFLAMMATORY RHEUMATIC DISEASES (IRD) WITH ONSET AFTER SARS-COV-2 INFECTION OR COVID-19 VACCINATION: A COHORT STUDY FROM THE COVID-19 & ASD COLLABORATIVE STUDY GROUP

134. Corrigendum to “Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial” [Int J Cardiol. 2022 Dec 15;369:5-11]

140. Signs and symptoms of COVID-19 in patients with multiple sclerosis

141. Sécurité et efficacité du tocilizumab dans la sclérodermie systémique : une étude rétrospective multicentrique franco-italienne.

143. 106P Synergistic effect of CDK4/6 inhibitors and standard chemotherapy sequential treatment on liposarcoma patient-derived primary culture

145. Radioactive ion beam opportunities at the new FRAISE facility of INFN-LNS

Catalog

Books, media, physical & digital resources